Symbols / LIVN Stock $71.75 +2.37% LivaNova PLC

Healthcare • Medical Devices • United Kingdom • NMS
LIVN (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Vladimir A. Makatsaria
Exch · Country NMS · United Kingdom
Market Cap 3.94B
Enterprise Value 3.75B
Income 107.14M
Sales 1.43B
FCF (ttm) 198.05M
Book/sh 21.96
Cash/sh 9.82
Employees 3,300
Insider 10d —
IPO Oct 19, 2015
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 36.61
Forward P/E 15.47
PEG 0.82
P/S 2.75
P/B 3.27
P/C —
EV/EBITDA 14.27
EV/Sales 2.61
Quick Ratio 1.01
Current Ratio 1.33
Debt/Eq 28.35
LT Debt/Eq —
EPS (ttm) 1.96
EPS next Y 4.64
EPS Growth —
Revenue Growth 14.30%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-05
Earnings (prior) 2026-05-06
ROA 5.27%
ROE 9.54%
ROIC —
Gross Margin 67.86%
Oper. Margin 14.39%
Profit Margin 7.47%
Shs Outstand 54.93M
Shs Float 54.68M
Insider Own 0.37%
Instit Own 104.55%
Short Float 7.07%
Short Ratio 4.75
Short Interest 3.38M
52W High 72.78
vs 52W High -1.42%
52W Low 41.02
vs 52W Low 74.94%
Beta 0.82
Impl. Vol. 32.50%
Rel Volume 1.09
Avg Volume 915.77K
Volume 998.81K
Target (mean) $80.18
Tgt Median $80.00
Tgt Low $67.00
Tgt High $95.00
# Analysts 11
Recom Buy
Prev Close $70.09
Price $71.75
Change 2.37%
About

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and difficult-to-treat depression. This segment also includes the development and clinical testing of LivaNova's aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, and other healthcare professionals, hospitals, and other medical institutions and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$80.18
Mean price target
2. Current target
$71.75
Latest analyst target
3. DCF / Fair value
$64.90
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$71.75
Low
$67.00
High
$95.00
Mean
$80.18

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-07 main Barclays Equal-Weight → Equal-Weight $76
2026-05-07 main Mizuho Outperform → Outperform $90
2026-05-07 main Baird Outperform → Outperform $76
2026-02-27 main Barclays Equal-Weight → Equal-Weight $73
2026-02-25 main Needham Buy → Buy $81
2026-01-09 main Barclays Equal-Weight → Equal-Weight $67
2026-01-07 main Stifel Buy → Buy $70
2025-12-19 init Keybanc — → Overweight $81
2025-12-17 main Mizuho Outperform → Outperform $72
2025-11-13 main Mizuho Outperform → Outperform $70
2025-11-13 main Baird Outperform → Outperform $70
2025-11-06 main Baird Outperform → Outperform $63
2025-09-03 reit Needham Buy → Buy $64
2025-08-21 main Barclays Equal-Weight → Equal-Weight $58
2025-05-20 up Wolfe Research Peer Perform → Outperform $60
2025-05-13 reit Needham Buy → Buy $64
2025-05-08 main Barclays Equal-Weight → Equal-Weight $55
2025-05-08 main Baird Outperform → Outperform $61
2025-03-17 reit Needham Buy → Buy $64
2025-03-07 main Barclays Equal-Weight → Equal-Weight $56
News
RSS: Latest LIVN news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-30 SHVARTSBURG ALEX Chief Financial Officer — 30,835 — —
2026-03-30 MAKATSARIA VLADIMIR A. Chief Executive Officer — 21,042 — —
2026-03-30 BOLTON STEPHANIE Officer — 17,815 — —
2026-03-30 TEZEL AHMET Officer — 3,408 — —
2026-03-30 POLETTI FRANCO Officer — 3,184 — —
2026-03-30 KOZMINA NATALIA Officer — 6,389 — —
2026-03-11 POLETTI FRANCO Officer — 2,140 $57.60 $123,264
2025-12-15 HUTCHINSON MICHAEL DAMON Officer — 2,254 — —
2025-12-15 PODLOGAR SUSAN M Director — 2,355 — —
2025-12-15 POLETTI FRANCO Officer — 967 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,388.05
+10.74%
1,253.44
+8.66%
1,153.55
+12.89%
1,021.80
Operating Revenue
1,388.05
+10.74%
1,253.44
+8.66%
1,153.55
+12.89%
1,021.80
Cost Of Revenue
448.18
+12.06%
399.95
+0.56%
397.73
+26.43%
314.58
Reconciled Cost Of Revenue
448.18
+12.06%
399.95
+0.56%
397.73
+26.43%
314.58
Gross Profit
939.87
+10.12%
853.48
+12.92%
755.82
+6.87%
707.23
Operating Expense
740.48
+2.22%
724.43
-1.35%
734.34
+12.18%
654.58
Research And Development
185.76
+1.78%
182.51
-5.83%
193.82
+24.40%
155.81
Selling General And Administration
548.81
+7.85%
508.88
+1.23%
502.70
+7.13%
469.24
Other Operating Expenses
5.90
-82.14%
33.04
-12.65%
37.83
+28.07%
29.54
Total Expenses
1,188.66
+5.72%
1,124.39
-0.68%
1,132.07
+16.81%
969.16
Operating Income
199.39
+54.50%
129.05
+500.91%
21.48
-59.21%
52.64
Total Operating Income As Reported
199.39
+54.50%
129.05
+288.40%
-68.50
+10.75%
-76.75
EBITDA
-111.86
-155.23%
202.52
+426.27%
38.48
+24.52%
30.90
Normalized EBITDA
278.67
+31.84%
211.37
+101.39%
104.95
-9.39%
115.83
Reconciled Depreciation
59.63
+16.60%
51.14
-15.96%
60.86
+5.29%
57.80
EBIT
-171.50
-213.29%
151.38
+776.62%
-22.37
+16.80%
-26.89
Total Unusual Items
-390.53
-4316.77%
-8.84
+86.70%
-66.47
+21.73%
-84.92
Total Unusual Items Excluding Goodwill
-390.53
-4316.77%
-8.84
+86.70%
-66.47
+21.73%
-84.92
Special Income Charges
-365.19
-1069.28%
-31.23
+65.29%
-89.97
+30.47%
-129.40
Other Special Charges
368.20
+1344.96%
25.48
—
—
Impairment Of Capital Assets
0.00
0.00
-100.00%
89.97
-30.47%
129.40
Write Off
1.11
-80.66%
5.75
0.00
0.00
Net Income
-242.47
-483.45%
63.23
+260.39%
17.55
+120.34%
-86.25
Pretax Income
-220.78
-350.01%
88.31
+208.72%
-81.23
-8.10%
-75.14
Net Non Operating Interest Income Expense
-30.30
+8.16%
-32.99
+10.44%
-36.84
+15.41%
-43.55
Interest Expense Non Operating
49.29
-21.86%
63.07
+7.17%
58.85
+21.98%
48.25
Net Interest Income
-30.30
+8.16%
-32.99
+10.44%
-36.84
+15.41%
-43.55
Interest Expense
49.29
-21.86%
63.07
+7.17%
58.85
+21.98%
48.25
Interest Income Non Operating
18.98
-36.88%
30.07
+36.63%
22.01
+368.64%
4.70
Interest Income
18.98
-36.88%
30.07
+36.63%
22.01
+368.64%
4.70
Other Income Expense
-389.87
-4933.14%
-7.75
+88.24%
-65.86
+21.81%
-84.23
Other Non Operating Income Expenses
0.66
-39.42%
1.10
+79.97%
0.61
-11.87%
0.69
Gain On Sale Of Security
-25.34
-213.19%
22.39
-4.74%
23.50
-47.15%
44.47
Gain On Sale Of Business
—
—
—
0.00
Tax Provision
21.64
-13.64%
25.06
+125.34%
-98.88
-994.72%
11.05
Tax Rate For Calcs
0.00
-25.99%
0.00
+35.12%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-82.01
-3168.80%
-2.51
+82.03%
-13.96
+21.73%
-17.83
Net Income Including Noncontrolling Interests
-242.47
-483.45%
63.23
+260.39%
17.55
+120.34%
-86.25
Net Income From Continuing Operation Net Minority Interest
-242.47
-483.45%
63.23
+260.39%
17.55
+120.34%
-86.25
Net Income From Continuing And Discontinued Operation
-242.47
-483.45%
63.23
+260.39%
17.55
+120.34%
-86.25
Net Income Continuous Operations
-242.47
-483.45%
63.23
+260.39%
17.55
+120.34%
-86.25
Net Income Discontinuous Operations
—
—
—
0.00
Normalized Income
66.05
-5.06%
69.57
-0.70%
70.06
+465.72%
-19.16
Net Income Common Stockholders
-242.47
-483.45%
63.23
+260.39%
17.55
+120.34%
-86.25
Diluted EPS
-4.45
-483.62%
1.16
+262.50%
0.32
+119.88%
-1.61
Basic EPS
-4.45
-480.34%
1.17
+254.55%
0.33
+120.50%
-1.61
Basic Average Shares
54.55
+0.64%
54.20
+0.56%
53.90
+0.75%
53.50
Diluted Average Shares
54.55
-0.10%
54.60
+0.74%
54.20
+1.31%
53.50
Diluted NI Availto Com Stockholders
-242.47
-483.45%
63.23
+260.39%
17.55
+120.34%
-86.25
Earnings From Equity Interest Net Of Tax
-0.05
-183.33%
-0.02
+82.69%
-0.10
-96.23%
-0.05
Gain On Sale Of PPE
4.13
0.00
0.00
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
2,606.05
+3.98%
2,506.39
+3.16%
2,429.56
+5.87%
2,294.77
Current Assets
1,101.61
-2.27%
1,127.19
+14.07%
988.16
+11.51%
886.14
Cash Cash Equivalents And Short Term Investments
635.55
+48.20%
428.86
+60.92%
266.50
+24.43%
214.17
Cash And Cash Equivalents
635.55
+48.20%
428.86
+60.92%
266.50
+24.43%
214.17
Receivables
264.59
+18.28%
223.70
-4.90%
235.22
+9.50%
214.82
Accounts Receivable
215.99
+11.82%
193.16
-10.19%
215.07
+17.46%
183.11
Gross Accounts Receivable
228.51
+11.78%
204.43
-9.98%
227.09
+16.47%
194.97
Allowance For Doubtful Accounts Receivable
-12.53
-11.10%
-11.28
+6.19%
-12.02
-1.32%
-11.86
Taxes Receivable
48.61
+59.13%
30.54
+51.62%
20.14
-36.47%
31.71
Inventory
164.70
+11.61%
147.57
-0.22%
147.89
+14.31%
129.38
Raw Materials
75.80
+5.35%
71.95
-12.13%
81.88
+16.92%
70.03
Work In Process
12.88
+4.49%
12.32
-4.49%
12.90
-16.81%
15.51
Finished Goods
76.03
+20.11%
63.30
+19.18%
53.11
+21.13%
43.84
Prepaid Assets
—
—
—
31.71
Restricted Cash
0.00
-100.00%
294.70
-5.35%
311.37
+3.29%
301.45
Assets Held For Sale Current
—
—
—
—
Hedging Assets Current
—
—
—
1.33
Other Current Assets
36.77
+13.62%
32.36
+19.06%
27.18
+3.27%
26.32
Total Non Current Assets
1,504.44
+9.08%
1,379.20
-4.32%
1,441.40
+2.33%
1,408.64
Net PPE
298.12
+37.32%
217.10
+5.89%
205.03
+12.03%
183.02
Gross PPE
540.33
+27.48%
423.85
+5.68%
401.06
+11.99%
358.14
Accumulated Depreciation
-242.21
-17.15%
-206.75
-5.47%
-196.04
-11.94%
-175.12
Properties
0.00
0.00
0.00
0.00
Land And Improvements
13.63
+12.68%
12.10
-18.82%
14.90
+1.81%
14.64
Buildings And Improvements
107.05
+22.01%
87.74
+3.78%
84.54
+4.88%
80.61
Machinery Furniture Equipment
297.69
+22.53%
242.95
+4.12%
233.34
+12.78%
206.89
Construction In Progress
60.31
+115.24%
28.02
+160.77%
10.74
-4.97%
11.31
Other Properties
61.64
+16.21%
53.05
-7.80%
57.53
+28.74%
44.69
Goodwill And Other Intangible Assets
1,022.80
+3.60%
987.30
-5.44%
1,044.12
-8.20%
1,137.35
Goodwill
792.84
+5.71%
750.01
-4.21%
782.94
+1.84%
768.79
Other Intangible Assets
229.96
-3.09%
237.29
-9.14%
261.18
-29.14%
368.56
Investments And Advances
20.29
-19.11%
25.08
+9.81%
22.84
+40.43%
16.27
Other Investments
17.29
—
—
—
Non Current Deferred Assets
110.98
-0.78%
111.86
-5.89%
118.86
+8488.01%
1.38
Non Current Deferred Taxes Assets
110.98
-0.78%
111.86
-5.89%
118.86
+8488.01%
1.38
Other Non Current Assets
15.69
+11.02%
14.13
+17.15%
12.06
-25.68%
16.23
Total Liabilities Net Minority Interest
1,406.07
+18.54%
1,186.13
+2.97%
1,151.93
+5.96%
1,087.15
Current Liabilities
808.07
+106.08%
392.12
+17.06%
334.98
+12.64%
297.40
Payables And Accrued Expenses
199.14
+4.20%
191.12
+3.84%
184.05
+26.82%
145.13
Payables
130.29
+27.51%
102.18
-1.92%
104.19
+14.72%
90.81
Accounts Payable
97.16
+39.34%
69.73
-13.75%
80.84
+8.79%
74.31
Other Payable
—
—
—
—
Current Accrued Expenses
68.85
-22.58%
88.94
+11.36%
79.87
+47.05%
54.31
Employee Benefits
13.57
+5.66%
12.85
-25.54%
17.25
+2.68%
16.80
Pensionand Other Post Retirement Benefit Plans Current
92.91
+15.37%
80.54
-14.89%
94.63
+31.09%
72.19
Total Tax Payable
33.13
+2.09%
32.46
+39.06%
23.34
+41.41%
16.50
Current Debt And Capital Lease Obligation
40.26
-53.75%
87.04
+228.80%
26.47
-19.32%
32.81
Current Debt
31.47
-59.65%
78.00
+330.70%
18.11
-22.71%
23.43
Other Current Borrowings
31.47
-59.65%
78.00
+330.70%
18.11
-22.71%
23.43
Current Capital Lease Obligation
8.79
-2.79%
9.04
+8.11%
8.36
-10.84%
9.38
Current Deferred Liabilities
11.51
+6.10%
10.85
+1.15%
10.72
+4.88%
10.23
Current Deferred Revenue
11.51
+6.10%
10.85
+1.15%
10.72
+4.88%
10.23
Other Current Liabilities
446.37
+15212.90%
2.92
-24.93%
3.88
-34.03%
5.89
Total Non Current Liabilities Net Minority Interest
597.99
-24.69%
794.01
-2.81%
816.95
+3.44%
789.75
Long Term Debt And Capital Lease Obligation
393.51
-33.27%
589.73
-3.94%
613.93
+12.11%
547.62
Long Term Debt
345.19
-37.20%
549.62
-3.33%
568.54
+9.74%
518.07
Long Term Capital Lease Obligation
48.33
+20.50%
40.10
-11.64%
45.39
+53.61%
29.55
Non Current Deferred Liabilities
9.59
-12.14%
10.91
-5.64%
11.57
+35.83%
8.52
Non Current Deferred Taxes Liabilities
9.59
-12.14%
10.91
-5.64%
11.57
+35.83%
8.52
Other Non Current Liabilities
97.41
-24.31%
128.70
+0.05%
128.63
-1.91%
131.14
Stockholders Equity
1,199.99
-9.11%
1,320.26
+3.34%
1,277.63
+5.80%
1,207.62
Common Stock Equity
1,199.99
-9.11%
1,320.26
+3.34%
1,277.63
+5.80%
1,207.62
Capital Stock
84.56
+1.69%
83.16
+0.75%
82.53
+0.13%
82.42
Common Stock
84.56
+1.69%
83.16
+0.75%
82.53
+0.13%
82.42
Share Issued
55.54
+2.02%
54.44
+0.92%
53.94
+0.17%
53.85
Ordinary Shares Number
54.65
+0.55%
54.35
+0.80%
53.92
+0.66%
53.56
Treasury Shares Number
0.89
+894.18%
0.09
+272.47%
0.02
-91.67%
0.29
Additional Paid In Capital
2,254.98
+1.55%
2,220.66
+1.42%
2,189.52
+1.47%
2,157.72
Retained Earnings
-1,145.72
-26.84%
-903.25
+6.54%
-966.48
+1.78%
-984.03
Gains Losses Not Affecting Retained Earnings
7.33
+109.14%
-80.17
-187.52%
-27.88
+42.05%
-48.12
Treasury Stock
1.17
+757.35%
0.14
+147.27%
0.06
-85.33%
0.38
Other Equity Adjustments
7.33
+109.14%
-80.17
-187.52%
-27.88
+42.05%
-48.12
Total Equity Gross Minority Interest
1,199.99
-9.11%
1,320.26
+3.34%
1,277.63
+5.80%
1,207.62
Total Capitalization
1,545.17
-17.37%
1,869.88
+1.28%
1,846.17
+6.98%
1,725.69
Working Capital
293.54
-60.07%
735.06
+12.54%
653.17
+10.94%
588.74
Invested Capital
1,576.64
-19.06%
1,947.89
+4.48%
1,864.28
+6.58%
1,749.12
Total Debt
433.77
-35.91%
676.77
+5.68%
640.40
+10.33%
580.43
Net Debt
—
198.77
-37.91%
320.15
-2.19%
327.33
Capital Lease Obligations
57.12
+16.22%
49.15
-8.57%
53.75
+38.08%
38.93
Net Tangible Assets
177.18
-46.79%
332.96
+42.59%
233.51
+232.26%
70.28
Tangible Book Value
177.18
-46.79%
332.96
+42.59%
233.51
+232.26%
70.28
Available For Sale Securities
3.00
—
—
—
Current Provisions
17.87
-9.09%
19.66
+29.19%
15.22
-51.15%
31.16
Derivative Product Liabilities
83.90
+61.92%
51.82
+13.72%
45.57
-46.81%
85.67
Financial Assets
36.55
+54.00%
23.73
-38.34%
38.50
-29.23%
54.39
Interest Payable
4.64
-51.07%
9.48
+20.91%
7.84
+10415.79%
-0.08
Investmentin Financial Assets
3.00
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
254.34
+38.95%
183.04
+144.33%
74.91
+7.14%
69.92
Cash Flow From Continuing Operating Activities
254.34
+38.95%
183.04
+144.33%
74.91
+7.14%
69.92
Net Income From Continuing Operations
-242.47
-483.45%
63.23
+260.39%
17.55
+120.34%
-86.25
Depreciation Amortization Depletion
59.63
+16.60%
51.14
-15.96%
60.86
+5.29%
57.80
Depreciation
41.93
+23.57%
33.93
-4.10%
35.38
+8.55%
32.60
Amortization Cash Flow
17.70
+2.84%
17.21
-32.43%
25.47
+1.09%
25.20
Depreciation And Amortization
59.63
+16.60%
51.14
-15.96%
60.86
+5.29%
57.80
Amortization Of Intangibles
17.70
+2.84%
17.21
-32.43%
25.47
+1.09%
25.20
Other Non Cash Items
34.10
+22.39%
27.86
-5.62%
29.52
+528.26%
-6.89
Stock Based Compensation
36.29
+6.95%
33.93
-6.65%
36.35
-18.87%
44.81
Provisionand Write Offof Assets
—
—
—
-6.56
Asset Impairment Charge
1.11
-80.72%
5.77
-94.38%
102.59
-20.71%
129.40
Deferred Tax
0.46
-93.30%
6.79
+105.94%
-114.43
-8221.22%
1.41
Deferred Income Tax
0.46
-93.30%
6.79
+105.94%
-114.43
-8221.22%
1.41
Operating Gains Losses
-8.38
-6213.87%
0.14
+100.60%
-22.91
+40.73%
-38.66
Gain Loss On Investment Securities
-6.90
+72.78%
-25.34
-10.62%
-22.91
+40.73%
-38.66
Unrealized Gain Loss On Investment Securities
3.62
+150.70%
-7.14
0.00
0.00
Change In Working Capital
369.97
+28228.48%
1.31
+103.77%
-34.62
-9.24%
-31.69
Change In Receivables
-10.71
-196.79%
11.06
+138.32%
-28.86
-500.08%
-4.81
Changes In Account Receivables
-10.71
-196.79%
11.06
+138.32%
-28.86
-500.08%
-4.81
Change In Inventory
-5.29
+21.70%
-6.76
+76.27%
-28.48
-10.90%
-25.68
Change In Payables And Accrued Expense
-17.04
-369.73%
-3.63
-113.66%
26.55
+1345.36%
-2.13
Change In Payable
-17.04
-369.73%
-3.63
-113.66%
26.55
+1345.36%
-2.13
Change In Account Payable
-13.45
+7.13%
-14.48
-175.45%
19.19
+646.72%
-3.51
Change In Other Working Capital
-1.09
-147.82%
2.27
+111.89%
-19.13
-191.72%
-6.56
Change In Other Current Assets
38.54
+2442.74%
-1.65
-110.75%
15.30
+104.41%
7.49
Change In Other Current Liabilities
365.55
0.00
0.00
—
Investing Cash Flow
-72.91
-51.40%
-48.16
-19.41%
-40.33
-4.99%
-38.41
Cash Flow From Continuing Investing Activities
-72.91
-51.40%
-48.16
-19.41%
-40.33
-4.99%
-38.41
Net PPE Purchase And Sale
-81.05
-72.06%
-47.11
-34.66%
-34.98
-31.92%
-26.52
Purchase Of PPE
-81.05
-72.06%
-47.11
-34.66%
-34.98
-31.92%
-26.52
Capital Expenditure
-81.05
-72.06%
-47.11
-34.66%
-34.98
-31.92%
-26.52
Net Investment Purchase And Sale
0.86
+175.04%
-1.14
+82.44%
-6.50
-120.33%
-2.95
Purchase Of Investment
-5.67
-396.06%
-1.14
+82.44%
-6.50
-120.33%
-2.95
Sale Of Investment
6.52
0.00
0.00
0.00
Net Business Purchase And Sale
—
0.00
0.00
+100.00%
-8.86
Purchase Of Business
—
0.00
0.00
+100.00%
-8.86
Net Other Investing Changes
7.28
+8080.90%
0.09
-92.29%
1.15
+1411.36%
-0.09
Financing Cash Flow
-285.66
-1639.86%
18.55
-13.65%
21.48
-92.33%
280.13
Cash Flow From Continuing Financing Activities
-285.66
-1639.86%
18.55
-13.65%
21.48
-92.33%
280.13
Net Issuance Payments Of Debt
-280.93
-419.35%
87.97
+210.00%
28.38
-90.01%
284.01
Issuance Of Debt
0.00
-100.00%
335.51
+571.03%
50.00
-90.15%
507.55
Repayment Of Debt
-280.93
-13.48%
-247.55
-1044.77%
-21.62
+90.33%
-223.54
Long Term Debt Issuance
0.00
-100.00%
335.51
+571.03%
50.00
-90.15%
507.55
Long Term Debt Payments
-280.93
-13.48%
-247.55
-1044.77%
-21.62
+90.33%
-223.54
Net Long Term Debt Issuance
-280.93
-419.35%
87.97
+210.00%
28.38
-90.01%
284.01
Short Term Debt Issuance
—
—
—
0.00
Short Term Debt Payments
—
—
-1.97
0.00
Net Short Term Debt Issuance
—
—
-1.97
0.00
Net Common Stock Issuance
—
-8.44
0.00
0.00
Common Stock Payments
—
-8.44
-12.48%
-7.50
+13.47%
-8.67
Repurchase Of Capital Stock
—
-8.44
-12.48%
-7.50
+13.47%
-8.67
Proceeds From Stock Option Exercised
-4.39
-109.49%
-2.10
+71.97%
-7.48
+6.75%
-8.03
Net Other Financing Charges
-0.34
+99.50%
-67.32
-11471.28%
0.59
-85.73%
4.15
Changes In Cash
-104.23
-167.94%
153.43
+173.65%
56.07
-82.01%
311.64
Effect Of Exchange Rate Changes
16.23
+309.53%
-7.75
-225.18%
6.19
+254.25%
-4.01
Beginning Cash Position
723.56
+25.21%
577.87
+12.07%
515.62
+147.90%
207.99
End Cash Position
635.55
-12.16%
723.56
+25.21%
577.87
+12.07%
515.62
Free Cash Flow
173.29
+27.48%
135.93
+240.40%
39.93
-8.00%
43.40
Interest Paid Supplemental Data
31.07
-20.11%
38.89
+5.36%
36.91
+93.81%
19.04
Income Tax Paid Supplemental Data
29.37
+84.57%
15.91
—
1.22
Change In Income Tax Payable
-3.59
-133.09%
10.85
+47.41%
7.36
+434.18%
1.38
Change In Tax Payable
-3.59
-133.09%
10.85
+47.41%
7.36
+434.18%
1.38
Common Stock Issuance
—
—
0.00
0.00
Issuance Of Capital Stock
—
—
0.00
0.00
Sale Of Business
—
—
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category